XML 38 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Stockholders' Equity
Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Class A Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Non-Controlling Interests
Beginning balance at Dec. 31, 2020 $ 3,904,231   $ 3,886,067   $ 1,468 $ 4,702,713   $ 11,170 $ (829,284)   $ 18,164
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Shares of class A common stock issued, net 2   2   2            
Restricted class A common stock earned 7,958   7,958     7,958          
Dividends reinvested 204   204     204          
Deferred directors’ compensation 125   125     125          
Net income 80,540   79,902           79,902   638
Other comprehensive income (loss) 114   114         114      
0.62 (91,349)   (91,349)           (91,349)    
Contributions from non-controlling interests 13,448                   13,448
Distributions to non-controlling interests (11,180)                   (11,180)
Ending balance at Mar. 31, 2021 $ 3,904,093   3,883,023   1,470 4,711,000   11,284 (840,731)   21,070
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Dividends declared on common stock (in dollars per share) $ 0.62                    
Beginning balance at Dec. 31, 2020 $ 3,904,231   3,886,067   1,468 4,702,713   11,170 (829,284)   18,164
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 213,008                    
Other comprehensive income (loss) (427)                    
0.62 (182,696)                    
Ending balance at Jun. 30, 2021 $ 3,956,955   3,930,961   1,470 4,719,231   10,743 (800,483)   25,994
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Dividends declared on common stock (in dollars per share) $ 1.24                    
Beginning balance at Dec. 31, 2020 $ 3,904,231   3,886,067   1,468 4,702,713   11,170 (829,284)   18,164
Ending balance at Dec. 31, 2021 $ 4,618,711 $ (477) 4,588,187 $ (477) 1,682 5,373,029 $ (2,431) 8,308 (794,832) $ 1,954 30,524
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06                    
Beginning balance at Mar. 31, 2021 $ 3,904,093   3,883,023   1,470 4,711,000   11,284 (840,731)   21,070
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Restricted class A common stock earned 7,895   7,895     7,895          
Dividends reinvested 211   211     211          
Deferred directors’ compensation 125   125     125          
Net income 132,468   131,595           131,595   873
Other comprehensive income (loss) (541)   (541)         (541)      
0.62 (91,347)   (91,347)           (91,347)    
Contributions from non-controlling interests 14,745                   14,745
Distributions to non-controlling interests (10,694)                   (10,694)
Ending balance at Jun. 30, 2021 $ 3,956,955   3,930,961   1,470 4,719,231   10,743 (800,483)   25,994
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Dividends declared on common stock (in dollars per share) $ 0.62                    
Beginning balance at Dec. 31, 2021 $ 4,618,711 (477) 4,588,187 (477) 1,682 5,373,029 (2,431) 8,308 (794,832) 1,954 30,524
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Shares of class A common stock issued, net 52,159   52,159   21 52,138          
Restricted class A common stock earned 8,472   8,472     8,472          
Dividends reinvested 246   246     246          
Deferred directors’ compensation 173   173     173          
Net income 100,263   99,687           99,687   576
Other comprehensive income (loss) 292   292         292      
0.62 (105,801)   (105,801)           (105,801)    
Contributions from non-controlling interests 5,040                   5,040
Distributions to non-controlling interests (9,241)                   (9,241)
Ending balance at Mar. 31, 2022 $ 4,669,837   4,642,938   1,703 5,431,627   8,600 (798,992)   26,899
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Dividends declared on common stock (in dollars per share) $ 0.62                    
Beginning balance at Dec. 31, 2021 $ 4,618,711 $ (477) 4,588,187 $ (477) 1,682 5,373,029 $ (2,431) 8,308 (794,832) $ 1,954 30,524
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 194,128                    
Other comprehensive income (loss) (1,230)                    
0.62 (211,613)                    
Ending balance at Jun. 30, 2022 $ 4,662,987   4,637,591   1,703 5,440,364   7,078 (811,554)   25,396
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Dividends declared on common stock (in dollars per share) $ 1.24                    
Beginning balance at Mar. 31, 2022 $ 4,669,837   4,642,938   1,703 5,431,627   8,600 (798,992)   26,899
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Restricted class A common stock earned 8,245   8,245     8,245          
Dividends reinvested 319   319     319          
Deferred directors’ compensation 173   173     173          
Net income 93,865   93,250           93,250   615
Other comprehensive income (loss) (1,522)   (1,522)         (1,522)      
0.62 (105,812)   (105,812)           (105,812)    
Distributions to non-controlling interests (2,118)                   (2,118)
Ending balance at Jun. 30, 2022 $ 4,662,987   $ 4,637,591   $ 1,703 $ 5,440,364   $ 7,078 $ (811,554)   $ 25,396
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Dividends declared on common stock (in dollars per share) $ 0.62